Testing equality of correlations of two paired binary responses from two treated groups in a randomized trial

Yanbo Pei, Man Lai Tang, Weng Kee Wong, Nian Sheng Tang

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We explore measuring Scleroderma patient disease improvement at the paired body part level and account for their correlation with the long term goal of possibly redefining disease progression using a shorter clinical examination. We propose using a binary outcome to measure disease progression at each paired body part level, construct tests for assessing equality of the correlations between groups for each paired body part and determine sample size requirements for such tests in a two-arm randomized clinical trial. Simulations are performed to evaluate properties of the tests and the accuracy of our sample size formulae. We demonstrate our method with data from a multi-center two-arm randomized clinical trial.

Original languageEnglish (US)
Pages (from-to)511-525
Number of pages15
JournalJournal of Biopharmaceutical Statistics
Volume21
Issue number3
DOIs
StatePublished - May 1 2011

Fingerprint

Randomized Trial
Binary Response
Human Body
Randomized Clinical Trial
Equality
Progression
Sample Size
Testing
Disease Progression
Scleroderma
Randomized Controlled Trials
Binary Outcomes
Outcome Assessment (Health Care)
Evaluate
Requirements
Term
Demonstrate
Simulation

All Science Journal Classification (ASJC) codes

  • Statistics and Probability
  • Pharmacology
  • Pharmacology (medical)

Cite this

Pei, Yanbo ; Tang, Man Lai ; Wong, Weng Kee ; Tang, Nian Sheng. / Testing equality of correlations of two paired binary responses from two treated groups in a randomized trial. In: Journal of Biopharmaceutical Statistics. 2011 ; Vol. 21, No. 3. pp. 511-525.
@article{6d4fb5f79ae547899ad59004b978ac8a,
title = "Testing equality of correlations of two paired binary responses from two treated groups in a randomized trial",
abstract = "We explore measuring Scleroderma patient disease improvement at the paired body part level and account for their correlation with the long term goal of possibly redefining disease progression using a shorter clinical examination. We propose using a binary outcome to measure disease progression at each paired body part level, construct tests for assessing equality of the correlations between groups for each paired body part and determine sample size requirements for such tests in a two-arm randomized clinical trial. Simulations are performed to evaluate properties of the tests and the accuracy of our sample size formulae. We demonstrate our method with data from a multi-center two-arm randomized clinical trial.",
author = "Yanbo Pei and Tang, {Man Lai} and Wong, {Weng Kee} and Tang, {Nian Sheng}",
year = "2011",
month = "5",
day = "1",
doi = "10.1080/10543406.2010.482682",
language = "English (US)",
volume = "21",
pages = "511--525",
journal = "Journal of Biopharmaceutical Statistics",
issn = "1054-3406",
publisher = "Taylor and Francis Ltd.",
number = "3",

}

Testing equality of correlations of two paired binary responses from two treated groups in a randomized trial. / Pei, Yanbo; Tang, Man Lai; Wong, Weng Kee; Tang, Nian Sheng.

In: Journal of Biopharmaceutical Statistics, Vol. 21, No. 3, 01.05.2011, p. 511-525.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Testing equality of correlations of two paired binary responses from two treated groups in a randomized trial

AU - Pei, Yanbo

AU - Tang, Man Lai

AU - Wong, Weng Kee

AU - Tang, Nian Sheng

PY - 2011/5/1

Y1 - 2011/5/1

N2 - We explore measuring Scleroderma patient disease improvement at the paired body part level and account for their correlation with the long term goal of possibly redefining disease progression using a shorter clinical examination. We propose using a binary outcome to measure disease progression at each paired body part level, construct tests for assessing equality of the correlations between groups for each paired body part and determine sample size requirements for such tests in a two-arm randomized clinical trial. Simulations are performed to evaluate properties of the tests and the accuracy of our sample size formulae. We demonstrate our method with data from a multi-center two-arm randomized clinical trial.

AB - We explore measuring Scleroderma patient disease improvement at the paired body part level and account for their correlation with the long term goal of possibly redefining disease progression using a shorter clinical examination. We propose using a binary outcome to measure disease progression at each paired body part level, construct tests for assessing equality of the correlations between groups for each paired body part and determine sample size requirements for such tests in a two-arm randomized clinical trial. Simulations are performed to evaluate properties of the tests and the accuracy of our sample size formulae. We demonstrate our method with data from a multi-center two-arm randomized clinical trial.

UR - http://www.scopus.com/inward/record.url?scp=79953197955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953197955&partnerID=8YFLogxK

U2 - 10.1080/10543406.2010.482682

DO - 10.1080/10543406.2010.482682

M3 - Article

C2 - 21442523

AN - SCOPUS:79953197955

VL - 21

SP - 511

EP - 525

JO - Journal of Biopharmaceutical Statistics

JF - Journal of Biopharmaceutical Statistics

SN - 1054-3406

IS - 3

ER -